Related Experiment Video

Updated: May 10, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Paeonol induces apoptosis in human ovarian cancer cells

Juan Yin1, Nanshun Wu, Fanqing Zeng

  • 1Department of Gynecology, The Ninth People's Hospital of Chongqing, Chongqing 400700, PR China.

Acta Histochemica
|June 18, 2013
PubMed

Insights

Paeonol effectively reduces ovarian cancer cell viability and induces apoptosis. This natural compound activates Caspase 3 and down-regulates survivin, showing potential as a chemotherapy agent.

Area of Science:

  • Pharmacology
  • Oncology
  • Molecular Biology

Background:

  • Paeonol is a recognized broad-spectrum antitumor agent used in Asia.
  • Its specific effects and mechanisms against ovarian cancer are not well-established.

Purpose of the Study:

  • To investigate the impact of paeonol on ovarian cancer cells.
  • To elucidate the underlying molecular mechanisms of paeonol's action in ovarian cancer.

Main Methods:

  • MTT (methyl thiazolyltetrazolium) assay to assess cell viability.
  • Flow cytometry and Hoechst staining to evaluate apoptosis rates.
  • Western blot analysis to measure cleaved Caspase 3 and survivin protein levels.

Main Results:

  • Paeonol significantly reduced ovarian cancer cell viability in a dose-dependent manner.
  • Paeonol treatment led to increased apoptosis rates compared to controls.
  • Cleaved Caspase 3 protein levels were elevated, while survivin levels were decreased post-treatment.

Conclusions:

  • Paeonol induces apoptosis in ovarian cancer cells.
  • The mechanism involves the activation of Caspase 3 and the down-regulation of survivin.
  • Paeonol demonstrates potential as a chemotherapeutic agent for ovarian cancer treatment.
Keywords:
ApoptosisCaspase 3Ovarian cancerPaeonolSurvivin

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.